“Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients”, J. Can. Res. Updates, vol. 14, pp. 114–120, Aug. 2025, doi: 10.30683/1929-2279.2025.14.13.